James Winbush, MD - Medicare Internal Medicine in Anderson, SC

James Winbush, MD is a medicare enrolled "Internal Medicine" physician in Anderson, South Carolina. He went to University Of South Carolina School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Pecora Medical, Pc and his current practice location is 803 N Fant St, Suite 3a, Anderson, South Carolina. You can reach out to his office (for appointments etc.) via phone at (864) 225-7401.

James Winbush is licensed to practice in New York (license number 221849) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912008806.

Contact Information

James Winbush, MD
803 N Fant St, Suite 3a,
Anderson, SC 29621-5700
(864) 225-7401
(864) 225-7201



Physician's Profile

Full NameJames Winbush
GenderMale
SpecialityInternal Medicine
Experience26 Years
Location803 N Fant St, Anderson, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • James Winbush attended and graduated from University Of South Carolina School Of Medicine in 1998
  NPI Data:
  • NPI Number: 1912008806
  • Provider Enumeration Date: 09/26/2006
  • Last Update Date: 04/16/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1951309616
  • Enrollment ID: I20140916002447

Medical Identifiers

Medical identifiers for James Winbush such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1912008806NPI-NPPES
366062MedicaidSC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208VP0014XPain Medicine - Interventional Pain Medicine 09409 (New York)Secondary
207R00000XInternal Medicine 221849 (New York)Primary
207LH0002XAnesthesiology - Hospice And Palliative Medicine 207641 (New York)Secondary
207R00000XInternal Medicine 36606 (South Carolina)Secondary
207RA0401XInternal Medicine - Addiction Medicine 2012522 (New York)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Kindred At Home- AndersonAnderson, SCHome health agency

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Pecora Medical, Pc27696606952

News Archive

New report raises questions about potential risks of chromium therapies

Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

LSUHSC receives HRSA grant to help students pursue practice primary care nursing degrees

The School of Nursing at LSU Health Sciences Center New Orleans has been awarded a $700,000 grant over two years by the Health Resources Services Administration (HRSA) of the US Department of Health and Human Services to help students pursuing advanced practice primary care nursing degrees meet educational expenses.

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James Winbush allows following entities to bill medicare on his behalf.
Entity NameHospital Physician Services - Southeast Professional Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760410385
PECOS PAC ID: 5597774554
Enrollment ID: O20100107000067

News Archive

New report raises questions about potential risks of chromium therapies

Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

LSUHSC receives HRSA grant to help students pursue practice primary care nursing degrees

The School of Nursing at LSU Health Sciences Center New Orleans has been awarded a $700,000 grant over two years by the Health Resources Services Administration (HRSA) of the US Department of Health and Human Services to help students pursuing advanced practice primary care nursing degrees meet educational expenses.

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

Read more Medical News

› Verified 2 days ago

Entity NamePecora Medical, Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275825994
PECOS PAC ID: 2769660695
Enrollment ID: O20140916002278

News Archive

New report raises questions about potential risks of chromium therapies

Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

LSUHSC receives HRSA grant to help students pursue practice primary care nursing degrees

The School of Nursing at LSU Health Sciences Center New Orleans has been awarded a $700,000 grant over two years by the Health Resources Services Administration (HRSA) of the US Department of Health and Human Services to help students pursuing advanced practice primary care nursing degrees meet educational expenses.

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

Read more Medical News

› Verified 2 days ago

Entity NamePrisma Health Medical Group-midlands
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275988321
PECOS PAC ID: 5991099707
Enrollment ID: O20160802001226

News Archive

New report raises questions about potential risks of chromium therapies

Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

LSUHSC receives HRSA grant to help students pursue practice primary care nursing degrees

The School of Nursing at LSU Health Sciences Center New Orleans has been awarded a $700,000 grant over two years by the Health Resources Services Administration (HRSA) of the US Department of Health and Human Services to help students pursuing advanced practice primary care nursing degrees meet educational expenses.

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Winbush is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
James Winbush, MD
Po Box 357,
Anderson, SC 29622-0357

Ph: (864) 225-7401
James Winbush, MD
803 N Fant St, Suite 3a,
Anderson, SC 29621-5700

Ph: (864) 225-7401

News Archive

New report raises questions about potential risks of chromium therapies

Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

Keryx completes randomization of last patient in Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals reported today the randomization of the last patient in its short-term study component of its Phase 3 registration program of Zerenex™ (ferric citrate), the Company's iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

LSUHSC receives HRSA grant to help students pursue practice primary care nursing degrees

The School of Nursing at LSU Health Sciences Center New Orleans has been awarded a $700,000 grant over two years by the Health Resources Services Administration (HRSA) of the US Department of Health and Human Services to help students pursuing advanced practice primary care nursing degrees meet educational expenses.

New fluorescent probes improve tumor detection in mice

Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at the University of California, San Diego and the Moores UCSD Cancer Center has developed biological probes that can stick to and light up tumors in mice.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Anderson, SC

Shahzad H Sheikh, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 118 Montgomery Dr, Anderson, SC 29621
Phone: 864-512-5849    Fax: 864-512-7575
Winston Cordell Floyd, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 400 North Fant Street, Suite G, Anderson, SC 29621
Phone: 864-224-2197    Fax: 864-225-0033
David W Potts, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 118 Montgomery Dr, Anderson, SC 29621
Phone: 864-512-3915    Fax: 864-260-3920
Sanjeev Kumar, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 819 N Fant St, Anderson, SC 29621
Phone: 864-261-1800    Fax: 864-261-1856
Rajeev Malik, M.D.
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 2000 E Greenville St, Ste 5000, Anderson, SC 29621
Phone: 864-224-5765    Fax: 864-224-1449
Daniel W. Grisham Sr., M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2000 E Greenville St Ste 2300, Anderson, SC 29621
Phone: 864-512-5780    Fax: 864-375-1155
Dr. William Muirhead Turner, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 131 Addis Cir, Anderson, SC 29626
Phone: 864-934-6833    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.